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The N-Myc Down Regulated Gene1 (NDRG1) Is a Rab4a
Effector Involved in Vesicular Recycling of E-Cadherin
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DeMarzo, Michael A. Carducci
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Cell to cell adhesion is mediated by adhesion molecules present on the cell surface. Downregulation of molecules that form the
adhesion complex is a characteristic of metastatic cancer cells. Downregulation of the N-myc down regulated gene1 (NDRG1)
increases prostate and breast metastasis. The exact function of NDRG1 is not known. Here by using live cell confocal
microscopy and in vitro reconstitution, we report that NDRG1 is involved in recycling the adhesion molecule E-cadherin
thereby stabilizing it. Evidence is provided that NDRG1 recruits on recycling endosomes in the Trans Golgi network by binding
to phosphotidylinositol 4-phosphate and interacts with membrane bound Rab4aGTPase. NDRG1 specifically interacts with
constitutively active Rab4aQ67L mutant protein and not with GDP-bound Rab4aS22N mutant proving NDRG1 as a novel Rab4a
effector. Transferrin recycling experiments reveals NDRG1 colocalizes with transferrin during the recycling phase. NDRG1 alters
the kinetics of transferrin recycling in cells. NDRG1 knockdown cells show a delay in recycling transferrin, conversely NDRG1
overexpressing cells reveal an increase in rate of transferrin recycling. This novel finding of NDRG1 as a recycling protein
involved with recycling of E-cadherin will aid in understanding NDRG1 role as a metastasis suppressor protein.
Citation: Kachhap SK, Faith D, Qian DZ, Shabbeer S, Galloway NL, et al (2007) The N-Myc Down Regulated Gene1 (NDRG1) Is a Rab4a Effector Involved
in Vesicular Recycling of E-Cadherin. PLoS ONE 2(9): e844. doi:10.1371/journal.pone.0000844
INTRODUCTION
Epithelial to mesenchymal transition is central to many physio-
logical and pathological processes including embryogenesis,
wound healing and metastasis [1]. Clinically the development of
cancer into an aggressive and life threatening disease is determined
by its potential and propensity to metastasize [2]. Metastasis
involves intravasation from site of origin into the circulatory
system and extravasation to the secondary sites. The whole process
is brought about by a complex interaction of the tumor cell with its
microenvironment [3]. An initial step of metastasis in solid tumors
involves downregulation of epithelial cell adhesion molecules,
thereby increasing the motility and invasiveness of tumor cells [4].
The adherens junction in epithelial cells is characterized by the
E-cadherin complex. E-cadherin is a 120 KD transmembrane
glycoprotein present on the surface of epithelial cells [5]. The
extracellular domain of the molecule forms a homodimer with E-
cadherin of neighboring cells in the presence of extracellular
calcium. The cytoplasmic domain of E-cadherin interacts with a,
b and c catenins [6]. It is thought that the complex interacts with
the actin cytoskeleton via the a-catenin molecule. However, recent
work by Yamada et.al., contests this notion and places the E-
cadherin complex as a more dynamic entity enabling morphoge-
netic changes and tissue development [7]. Loss of E-cadherin by
deletion or gene silencing is among the most common adhesion
molecule alteration in several cancer types that includes those of
the bladder, stomach, breast, colon, kidneys and prostate [8,9].
The N-myc down regulated gene 1 (NDRG1) has been reported
to be a prostate and breast cancer metastasis suppressor gene
[10,11]. NDRG1 gene is conserved in a wide variety of multi-
cellular organisms including Caenorhabditis, Xenopus, Drosophila and
sun flower indicating that it may play a role in an essential
biological process [12,13].
The fact that germline mutations of NDRG1 in humans and
NDRG1 knockout mouse models do not develop cancers suggests
that NDRG1 may not be involved with cancer initiation but at
a later event in cancer progression which includes metastasis
[14,15]. However, the exact function by which NDRG1 suppresses
metastasis is unknown. It is expressed in a wide variety of tissues
including the prostate [16]. Overexpression of NDRG1 leads to
differentiation of cancer cells. In experimental settings NDRG1 is
induced by a wide variety of chemicals including histone deacetylase
inhibitors and differentiating agents like retinoic acid [17]. By
immunohistochemical analysis of various human tissues NDRG1
has been shown to localize to nucleus and cytoplasm as well as close
to the adherens junctions [16]. It is hypothesized that NDRG1 plays
a role in stabilizing the adherens junctions [16]. In this report
evidence is provided that NDRG1 is a Rab4a effector protein that
localizes to perinuclear recycling/sorting vesicles in the Trans Golgi
network by binding to phophatidylinositol 4-phosphate and is
involved in recycling of E-cadherin. This is the first demonstration
providing evidence that NDRG1 is a Rab4a effector recruiting to
recycling/sorting endosomes.
RESULTS AND DISCUSSION
To investigate a role of NDRG1 in stabilizing the adherence
junction, NDRG1 gene expression was knocked down in the
prostate cancer cell lines DU-145 and LNCaP using a U6 based
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protein levels but not other proteins of the E-cadherin complex
investigated (Figure 1A). DU-145 cells transfected with NDRG1 or
Flag-tagged NDRG1 constructs when treated with cycloheximide,
a protein translation inhibitor, showed an increase in E-cadherin
levels as compared to mock transfected controls (Figure 1B). This
indicates that NDRG1 directly or indirectly stabilizes the E-
cadherin protein increasing its longevity in the cell.
To investigate whether there is a correlation between NDRG1
and E-cadherin expression in prostate cancer tissues, both proteins
were analyzed immunohistochemically on a prostate cancer tissue
array by our published methods [18]. A total of thirty two prostate
cancer tumors were evaluated. NDRG1 was found to be primarily
cytoplasmic with some membrane and nuclear localization. When
individual tumors were analyzed for co-expression of the two
proteins, a highly significant positive correlation was revealed
(r
2=0.8448, Figure 1C). This finding suggests that presence of
NDRG1 may be necessary for the stability of the E-cadherin
protein in prostate tumors.
Intrigued by such a remarkable correlation between the
expression of the two proteins we sought to understand the
functional relation, if any, between NDRG1 and E-cadherin.
Interaction of E-cadherin with the catenins leads to clustering of E-
cadherin thereby strengthening adhesion [6]. To understand the
possible role of NDRG1 in stabilizing E-cadherin, we first
investigated whether the stabilization was due to association of
NDRG1 to the E-cadherin complex. None of the proteins of the
E-cadherin complex co-immunoprecipitated with flag-tagged
NDRG1 in DU-145 and CWR22R prostate cancer cells,
suggesting other mechanisms involving NDRG1 may play a role
in the stability of E-cadherin (Figure 2D and data not shown).
E-cadherin has a short half life of 5–10h. The assembly and
turnover of the E-cadherin molecule involves its phosphorylation,
ubiquitinylation, internalization by endosomes, and subsequent
lysosomal or proteasomal degradation or recycle back to the cell
surface [19]. This vesicular to and fro movement of E-cadherin
from the cell surface to the interior and back is central to the
dynamics and stability of the adhesion complex [20,21]. Given the
fact that NDRG1 is induced by calcium ionophores [22] and E-
cadherin turnover is calcium dependent, the location of NDRG1
and E-cadherin in DU-145 cells was investigated after calcium
chelation and subsequent recovery in calcium supplemented
media by immunoflourescence. Our immunofluorescent data
revealed that NDRG1 strongly localizes with E-cadherin during
the recovery/recycling phase (Supplementary Figure S1). Howev-
er, due to scanty cytoplasm and large nucleus of DU-145 cells it
was hard to discern, even with very thin Z-sections, whether the
co-localization seen was apparent or real.
To confirm whether NDRG1 indeed colocalizes with recycling
E-cadherin and also test whether this is true in other cells, live
CWR22R prostate cancer cells were labeled with mouse mono-
clonal antibody that recognizes the extracellular domain of E-
Figure 1. Presence of NDRG1 stabilizes E-cadherin in prostate cancer cells. (A) Western blot analysis of DU-145 and LNCaP cells transfected with
pSHAG1NDRG1 constructs. Control cells were transfected with pSHAG1Luc vector. Knockdown of NDRG1 downregulates E-cadherin protein levels
but not other proteins of the E-cadherin complex or PCNA, actin was used as a loading control. (B) DU-145 cells transfected with pCMVNDRG1 and
pCMVNDRG1flag constructs, 48 h post transfection cells were treated with cycloheximide (10 mM) for 6h and probed for E-cadherin by western
blotting. E-cadherin is stabilized in cells overexpressing NDRG1 or NDRG1flag. (C) Immunohistochemical analysis of prostate cancer tissue array shows
representative tumors stained for both NDRG1 and E-cadherin. Analysis of average intensity of both the proteins reveal NDRG1 and E-cadherin
expression correlates significantly (n=32, r
2=0.8448). (D) DU145 cells transfected with NDRG1-Flag constructs were lysed with cell lysis buffer,
immunoprecipitated and probed for proteins of the E-cadherin complex, none of the probed proteins of the E-cadherin complex interacts with
NDRG1. (Figures A, B and D are representatives of at least three independent experiments.)
doi:10.1371/journal.pone.0000844.g001
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internalization of the antibody and then immediately chelated
with EDTA before placing them back to 37uC. Cells were then
restored to calcium supplemented media and immunoprobed at
different timepoints with antibody against NDRG1 and secondary
anti-mouse antibody to detect endocytosed recycling E-cadherin.
Punctate staining for NDRG1 was observed in the cytoplasm.
Intense staining for both the proteins was seen near the
perinuclear region where the two proteins colocalized. As the
cells spread, structures positive for both the proteins resolved into
more tubular-vesicular morphology and NDRG1 was seen to
colocalize with recycling E-cadherin (Figure 2A).
Vesicular transport in the cell is guided by small ras-like
GTPases or RabGTPases of ,20–30 KD that shuttle between the
cytoplasm and vesicle membranes. Together the different Rab
proteins act as molecular switches that spatially and temporally
regulate protein trafficking, recycling, and degradation [23].
Endocytosed surface molecules and receptors pass through vesicles
decorated by different Rab proteins and effectors before they are
degraded or recycled back to the cell surface [24]. Rab11 is known
to be associated with recycling E-cadherin [25].
Does NDRG1 play a role in vesicular transport was the next
question addressed. A discontinuous sucrose density ultracentrifu-
gation was employed to reveal the localization of NDRG1 in DU-
145 cells after calcium chelation using EDTA. Fractions collected
and subjected to western blotting revealed that NDRG1 strongly
localizes to a membrane organelle in the presence of EDTA
(Figure 2B and 2C). These fractions were positive for E-cadherin
(Figure 2C). However, the presence of E-cadherin was evident
only when an increased amount of each fraction was loaded
indicating all organelles positive for NDRG1 were not positive for
E-cadherin. That this is a common feature of all cells and not
specific for a particular cell type was confirmed when the same
findings held true in adenovirus transformed human embryonic
kidney (HEK293) cells (Figure 2D).
To decipher the identity of the organelle to which NDRG1
localized NDRG1 positive fractions were probed with different
organelle markers. NDRG1 positive fractions were positive for,
Rab4 and Rab11, (markers for recycling/sorting endosomes) and
Rab7 (late endosomal marker) while negative for Rab5a (early
endosomal marker), LAMP1 (lysosomal marker), GRP78 (endo-
plasmic reticulum marker), and CoxI (mitochondrial marker),
(Figure 2C and D). This indicated that NDRG1 containing
organelles co-fractionates with recycling/sorting and late endo-
somes. Also, the distribution of NDRG1 and Rab4a was
remarkably similar. In order to investigate whether NDRG1
physically associates with Rab4a or other RabGTPases, HEK293
cells were transfected with NDRG1 Flag constructs. NDRG1
specifically immunoprecipitated with Rab4a and this interaction
was sensitive to TritonX100 (Figure 3A and 3C). A reciprocal
immunoprecipitation using Rab4a antibody under similar condi-
tion when performed and probed for flag-tagged NDRG1 revealed
a positive interaction between the two proteins confirming our
finding (Figure 3B). None of the other RabGTPases (Rab5, Rab11
and Rab7) which are located on distinct endosomal membranes
immunoprecipitated with NDRG1 (Figure 3A).
We hypothesized that the interaction between NDRG1 and
Rab4a may occur on the surface of endosomal membranes rich in
Figure 2. NDRG1 colocalizes with recycling E-cadherin and co-fractionates with recycling endosome. (A) Immunofluorescence analysis of CWR22R
cells labeled with E-cadherin antibody and chelated with EDTA. Cells were replated on calcium supplemented media and probed with primary
antibody against NDRG1 and secondary antibodies against NDRG1 and E-cadherin after different time intervals. NDRG1 colocalizes with recycling E-
cadherin. (B) Organelle fractions (from top to bottom) of DU-145 cells chelated with EDTA and subjected to a sucrose density gradient centrifugation
were analyzed by western blotting. NDRG1 strongly localizes to a membrane organelle in cells treated with EDTA. (C) Western blotting of EDTA
chelated NDRG1 positive fractions in DU-145 cells reveals NDRG1 cofractionates with E-cadherin (D) Western blotting of NDRG1 positive fractions
after sucrose density gradient in HEK293 cells reveals NDRG1 co-fractionates with recycling and late endosomal markers cells after Ca
2+ chelation. (All
figures are representatives of at least three independent experiments.)
doi:10.1371/journal.pone.0000844.g002
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[26]. To ascertain this, recombinant flag-tagged NDRG1 protein
were generated in S2 Drosophila insect cells and purified using
a combination of anion-exchange and affinity chromatography.
Rab4a was produced as a GST tagged protein in BL21 E.coli cells
(Figure S2A and B). RabGTPases shuttle between cytoplasm and
endosomal membranes, they are converted to the GTP-bound
form by a GTP/GDP- exchange factor and localizes to the
membranes of endosomes recruiting Rab effector proteins on the
surface of the vesicle. Therefore, recombinant Rab4a was loaded
with GTPcS and GDP and incubated with M2-agarose bound
purified NDRG1flag protein. NDRG1 specifically interacted with
GTPcS-bound Rab4a and not GDP-bound Rab4a indicating that
NDRG1 indeed has an affinity for membrane-localized Rab4a
(Figure 3D). This suggested that NDRG1 is a candidate Rab4a
effector protein. To investigate whether this is true in vivo we
employed constitutive active and inactive mutants of flag tagged
Rab4a. The Rab4aQ67L is GTPase deficient and is constitutively
active whereas the Rab4aS22N is GDP-bound and inactive [27].
Immunoprecipitation using these mutants revealed NDRG1
specifically binds to wild type and GTP-bound Rab4aQ67L but
does not bind to the GDP-bound Rab4aS22N mutant corroborating
our in vitro pull-down experiments (Figure 4A). We further validated
these findings by transfecting EGFP fusion constructs of wild type
and Rab4a mutants in HEK293 cells stably transfected with
NDRG1DsRed2 fusion constructs. Stable expression of NDRG1
as a DsRed2 fusion protein showed NDRG1DsRed2 to be primarily
a cytoplasmic protein recruiting to discrete vesicles ranging from 30–
300nm in size with an average size of 50nm that had an asymmetric
distribution in the perinuclear region (Figure 4B, Movie S1).
NDRG1DsRed2 also localized to membrane ruffles, a structure
whose maintenance is closely associated with endosome function
(Figure 4B) [28]. Vesicular wild type Rab4aEGFP was seen to
colocalize with NDRG1DsRed2 at the perinuclear region while
dominant negative inactive S22N mutant EGFP protein did not
colocalize with NDRG1 protein (Figure 4C). The constitutively
active Q67L mutant EGFP protein on the other hand showed
marked colocalization with NDRG1DsRed2 at the perinuclear
region (Figure 5A). For a protein to qualify as a RabGTPase effector
it should recognize and interact with GTP bound RabGTPase [23].
Our in vitro and in vivo data indicates that NDRG1 does qualify as
a Rab4a effector protein.
Rab4a is known to recruit many effector molecules on the
surface of endosomes [23]. Our pull-down experiment suggested
the likelihood of Rab4a recruiting NDRG1 onto the vesicles.
However the fact that the dominant negative S22N mutant failed
to solubilize vesicular NDRG1 suggested NDRG1 recruitment
onto endosomal membranes might be independent of Rab4a
protein. To understand the recruitment of NDRG1 on recycling/
sorting vesicles, recycling/sorting vesicles were purified by
immunoisolation using Rab11 antibody bound to ProteinA
magnetic beads from a population of early/recycling endosomes,
purified using flotation gradient ultracentrifugation.
35S-labeled in-
vitro translated NDRG1 was incubated with purified recycling
endosomes in the presence of GTPcS-bound Rab4a. HEK293
cytosol was included to investigate the role of other cytosolic
proteins in the recruitment. NDRG1 recruited onto the surface of
endosomes independent of Rab4a or other cytosolic proteins
(Figure 5B). This suggests that NDRG1 recruits to recycling
vesicles and interacts directly with Rab4a after recruitment.
It is also possible that NDRG1 recruits on vesicles after binding
to endogenous membrane-bound Rab4a and does not need any
exogenous GTPcS-bound Rab4a protein for membrane recruit-
ment. We speculated that recruitment of NDRG1 onto endosomal
membranes may occur by its interaction with lipids on endosomal
membranes. Rab5 has been known to recruit phosphatidylinositol
kinases that modify lipids and create membrane domains for
recruitment of effector proteins [29]. To investigate this possibility
purified NDRG1Flag protein from insect cells was used in a lipid-
protein overlay analysis. NDRG1 strongly interacted with
phosphatidylinositol 4-phosphate (Figure 5C), a lipid concentrated
and maintained by ARF1 in the Trans Golgi Network, and is
involved with vesicle formation, transportation and sorting cargo
proteins to endosomes [30]. However, NDRG1 did bind weakly to
Figure 3. NDRG1 interacts with GTP-bound Rab4GTPase. (A) HEK293 cells transfected with NDRG1Flag vector lysed in Tris-buffered saline,
immunoprecipitated using M2-agarose and probed for different RabGTPase by western blotting. NDRG1 interacts specifically with Rab4a. Lanes 2 and
3 are immunoprecipitation from two different experiments. (B) Reciprocal immunoprecipitation using Rab4a antibody and probed with flag antibody
detects a single band in NDRG1 flag transfected cell lysates. (C) Immunoprecitation of NDRG1 carried out in cell lysis buffer containing 1% TritonX100
and in Tris-buffered saline (TBS). Binding of NDRG1 to Rab4a is sensitive to TritonX100. (D) NDRG1flag purified from Drosophila S2 cells and bound to
M2 agarose were incubated with purified Rab4aGST loaded with GTPcS and GDP. Bound proteins were analyzed by western blotting, NDRG1
specifically binds to Rab4aGST loaded with GTP.
doi:10.1371/journal.pone.0000844.g003
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mitochondria and its oxidation is involved in induction of
apoptosis [31].The biological consequence of NDRG1 binding
to cardiolipin remains unknown. Thus, this data indicates that
NDRG1 recruits onto vesicles by binding to phosphatidylinositol
4-phosphate and interacts with membrane bound Rab4a.
Further, localization of NDRG1 in live NDRG1DsRed2-
HEK293 cells was studied by live cell confocal microscopy.
Figure 5. NDRG1 recruits to recycling endosome by binding to phosphatidylinositol 4-phosphate and interacts with Rab4GTPase. (A)
NDRG1DsRed2-HEK293 stable cells transfected with Rab4aQ67LEGFP mutant reveal NDRG1 interacts with Rab4aQ67LEGFP at the perinuclear region.
(B) In vitro translated NDRG1 was incubated with purified recycling endosomes in the presence of recombinant GTPcS bound Rab4a and HEK293
cytosol.NDRG1 recruits on recycling endosomes independent of Rab4a or other cytosolic proteins. (C) Lipid overlay assay using purified NDRG1flag
protein (1ug) shows NDRG1 binds strongly to phosphatidylinositol 4-phosphate. (All figures are representatives of at least three independent
experiments.)
doi:10.1371/journal.pone.0000844.g005
Figure 4. NDRG1 interacts with wild type and Q67L mutant of Rab4a but not with S22N mutant. (A) Immunoprecipitation of flag-tagged wild type
and mutant Rab4a reveals NDRG1 interacts specifically with wild type and GTP-bound Q67L mutant of Rab4a. (B) Confocal microscopy of
NDRG1DsRed2-HEK293 stable cells reveal NDRG1 localize asymmetrically around the nucleus (N) to discrete perinuclear (PN) vesicles. NDRG1 is also
seen to localize to membrane ruffles (arrow). Scale bar indicates 10mm length. (C) Wild type and GDP-bound (S22N) EGFP fusion of Rab4a transfected
in NDRG1DsRed2-HEK293 stable cells reveal vesicular NDRG1 colocalizes with wild type Rab4a but not with the S22N mutant.
doi:10.1371/journal.pone.0000844.g004
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dergoing both fission and homotypic fusion (Movie S2). NDRG1
vesicles also assume long tubular shapes (5–20 mm in length) and
rapidly move from the perinuclear space to the peripheral region
near the plasma membrane, a feature that is characteristic of
perinuclear recycling/sorting compartment (Movie S2) [32,33].
To confirm the involvement of NDRG1 in recycling,
NDRG1DsRed2-HEK293 cells were pulsed with Alexa-fluor-
488 conjugated transferrin for 5min to load the early endosome
and 60min to load the recycling endosomes and followed by live
cell confocal microscopy. Vesicular NDRG1DsRed2 specifically
interacted with recycling transferrin and there was a spatial
difference between the transferrin positive early endosomal vesicles
that were localized near the plasma membrane and NDRG1
containing vesicles that were localized in the perinuclear region
(Figure 6A, Movie S3). NDRG1 vesicles positive for transferrin
were seen to recycle transferrin back to the cell surface. To
understand the role of NDRG1 in the recycling process we
employed transferrin recycling assays on NDRG1 knockdown and
NDRG1 overexpressing HEK293 cells. Serum starved cells were
loaded with biotinylated transferrin for 1h to load the endosomal
recycling compartment and recycling was initiated with excess of
transferrin (1 mg/ml). Biotinylated transferrin within the endoso-
mal recycling compartment had a slower recycling rate in NDRG1
knockdown cells as compared to control shRNA vector transfected
cells (Figure 6B). This data was also confirmed when recycled
transferrin was compared between NDRG1 knockdown and
control transfected cells (Figure 6B graph). However, a difference
in recycling rates was evident only at early time points (5min and
15min) and NDRG1 knockdown cells were able to recycle most of
the endocytosed transferrin after 30 min. Overexpression of
NDRG1 in HEK293 cells increased the rate of transferrin
clearance from the endosomal recycling compartment as com-
pared to vector transfected control cells (Figure 6C). This was also
demonstrated by an increased rate of recycled transferrin in
NDRG1 overexpressing cells as compared to vector transfected
control cells (Figure 6C graph). Thus both our knockdown and
overexpression data demonstrates a functional role of NDRG1 in
the recycling pathway. A delay in transferrin recycling has been
noted after knockdown or knockouts of a number of protein
involved with vesicular transport, specifically proteins belonging to
the EHD family that localizes to tubular vesicular regions of
recycling endosomes [34]. Interestingly, during the revision of this
manuscript a report by Taketomi et al., demonstrated impaired
exocytosis and maturation of mast cells in NDRG1 knockout mice.
Mast cells from NDRG1 knockout mice displayed 50% less
exocytosis and exhibited fewer, smaller and irregular secretory
granules as compared to wild type controls [15]. Forced expression
of NDRG1 in mast cells by the same group had demonstrated an
increase in exocytosis and degranulation [35]. Arguing that the
exocytosis process and the endosome recycling pathway shares
common protein components and are functionally related, our
data demonstrating a delayed kinetics of transferrin recycling in
NDRG1 knockdown cells and increase rate of transferrin recycling
in NDRG1 overexpressing cells is consistent with the findings of
Taketomi et al., [15,36].
As indicated above NDRG1 containing vesicles ranged in size
from 30–300 nm. Large vesicle size (300 nm) suggests that besides
recycling, NDRG1 may also have secretory function [37]. After
extensive literature search and surveying proteomic data of
prostasome, a vesicular body secreted by the prostate that helps
in sperm motility, NDRG1 was found to be one of the protein
components of prostasome besides other proteins involved in
vesicular transport [38]. Recently, by confocal microscopy and
BRET analysis, NDRG1 was shown to colocalize with APO AI
and AII and may be involved with secretion or transport of these
lipoproteins [39]. Interestingly, a plant homolog of NDRG1 is also
expressed in secretory cells of reproductive tissues [13]. Although
this report does not investigate the role of NDRG1 in secretory
pathways, it may not be surprising if NDRG1 also has secretory
functions as many proteins of the endocytic and exocytic pathways
overlap [15,36].
Having established that NDRG1 is involved with recycling/
sorting endosomes, involvement of NDRG1 with E-cadherin
recycling was studied using live cell confocal microscopy. For this
purpose an E-cadherinEGFP construct that is known to be func-
tional and which also interacts with cytoplasmic catenins was
employed [7]. Transient transfection of E-cadherinEGFP construct
in NDRG1DsRed2-HEK293 cells was followed by calcium
chelation and recovery in calcium-supplemented media. Live cell
confocal images show endocytosed E-cadherinEGFP to be vesicular
and are enriched at the perinuclear space before being recycled back
to the cell surface. NDRG1DsRed2 vesicles both near the peri-
nuclearspaceand closetothe membrane fusewith E-cadherinEGFP
vesicles as they are trafficked back to the cell surface confirming its
involvement with recycling E-cadherin (Figure 7 and Movie S4).
Although NDRG1 has been reported to be downregulated in
a variety of cancers which includes the cancers of prostate, breast,
colon and oesophagus there are also reports that NDRG1 is
upregulated in hepatic, pancreatic and kidney cancers [10,11,40–
43]. Induction of NDRG1 in these tumors is speculated to be in
response to tumor stress or hypoxia and NDRG1 is proposed as
a marker of tumor hypoxia [44]. However, in pancreatic cancer,
cellular differentiation and not hypoxia was demonstrated to be
the determining factor for NDRG1 expression [42]. In renal
cancer, induction of NDRG1 in the tumor tissue was restricted to
infiltrating macrophages and not cancer cells [43]. Also none of
the reports demonstrate experimental overexpression of NDRG1
leading to increased proliferation or invasion in cellular or animal
models of these cancers. Mutation status of NDRG1 in tumors
overexpressing NDRG1 is lacking, it is also likely that NDRG1 in
these tumors may be non functional.
Apart from an alpha-beta hydrolase motif, the functionality of
which remains questionable [45], NDRG1 has no known protein
motifs that would impart it a function. Germline mutations in
NDRG1 causes Charcot-Marie Tooth Disease type 4D, a de-
myelinating disorder [14]. Myelin biogenesis involves coordinated
activities of both the endocytic and the exocytic pathways [46].
NDRG1 mutation may lead to perturbation in one or both the
pathways leading to the observed phenotype. In summary, this
report provides evidence defining NDRG1 function in vesicular
transport. The data presented here indicates that NDRG1 is
a Rab4a effector that can localize to the recycling/sorting
endosomes. Being a Rab4a effector it is very likely that NDRG1
may also be involved with vesicular transport of other cargo
molecules that may account for its metastasis suppressor function.
Our report suggests the involvement of NDRG1 in recycling of at
least one metastasis suppressor, the E-cadherin molecule. Also, the
fact that NDRG1 and E-cadherin protein levels correlate
significantly in tumors from prostate cancer patients renders
clinical significance to our in vitro findings.
MATERIALS AND METHODS
Constructs
A U6 promoter based vector (pSHAG vector and pSHAGLuc
control vector, a kind gift from Dr. Greg. Hannon, Cold Spring
Habor) was used to generate shRNA against NDRG1. Three
NDRG1 a Rab4a Effector
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according to the software (http://katahdin.cshl.org:9331/RNAi)
for bases 144–172, 304–331 and 464–491 (NM_006096). For
cloning NDRG1 full length gene in a mammalian expression
vector NDRG1 was amplified from a prostate cDNA library
(Clontech) using reverse primers that had a Flag sequence
(DYKDDDDK) in-frame with the NDRG1 coding sequence,a
stop codon was introduced after the FLAG sequence. The PCR
product was cloned into the XhoI/EcoRI site of the pDsRed2N1
(Clontech) vector and sequenced. The NDRG1 DsRed2 fusion
vector was made by amplifying NDRG1 from the prostate cDNA
library and cloning it in-frame with the DsRed2 protein. Rab4a
wild type and mutant EGFP fusion vectors were a kind gift from
Dr. Marci Scidmore (Cornell University). These vectors were used
as a template to PCR amplify and generate N-terminal Flag
tagged Rab4a and mutant constructs.
Figure 6. NDRG1 affects transferrin recycling kinetics. (A) Live Cell confocal images of stable NDRG1DsRed2-HEK293 cells pulsed with transferrin for
5 min to load the early endosome and 60 min to load recycling/sorting vesicles reveal NDRG1DsRed2 colocalizes with recycling transferrin. The lower
image panel is a still from Movie S3. (B) Transferrin recycling assay in HEK293 cells transfected with NDRG1 shRNA and control shRNA reveal a slower
clearance of biotinylated transferrin from the endosomal recycling compartment (ERC) in knockdown cells. The graph below shows the percentage of
recycled transferrin (see methods) in the NDRG1 knockdown (m) as compared to control (&) cells. The error bars represent standard deviation of 3
independent experiments. (C) Transferrin recycling assay in HEK293 cells transfected with NDRG1flag constructs and empty vector constructs reveal
a faster clearance of biotinylated transferrin from the ERC in NDRG1 overexpressing cells as compared to empty control cells. The graph below shows
the percentage of recycled transferrin in the NDRG1 overexpressing cells (m) as compared to control (&) cells.
doi:10.1371/journal.pone.0000844.g006
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shRNA constructs were transfected in prostate cancer cell lines
using Lipofectamine2000 Reagent (Invitrogen) and proteins were
harvested 24, 48 and 72 h post-transfection for western blotting.
Control cells were transfected with pSHAG1luc constructs that
targets the luciferase gene. NDRG1 shRNA construct targeting
region 304–331 bases was selected as it gave a maximum
knockdown.
Immunofluorescence and Immunoprecipitation
DU-145 cells were chelated with 2.5 mM EDTA and plated on
coverslips in calcium-supplemented media. Cells were fixed at
different time points with 3.6% formaldehyde and permeablized
with 0.125% TritionX100 before being probed with antibodies
against NDRG1 (a kind gift from Dr. Therese Commes,
Universite Montpellier II) and E-cadherin (Calbiochem). For live
cell labeling and recycling experiment CWR22R cells were grown
on 60mm dishes and washed with PBS before being chilled on ice.
Cells were labeled with E-cadherin antibody (mouse monoclonal
1ug/ml, Calbiochem) in PBS supplemented with 1% BSA for
30 min. Cells were washed with ice cold PBS for 5 times and
restored back to 37uC and 5%CO2 environment after addition of
RPMI and subjected immediately to calcium chelation by addition
of EDTA (2.5 mM). Control cells were subjected similarly without
the addition of E-cadherin antibody during labeling. After
chelation cells were plated on glass coverslips and fixed at different
time points with 3.6% formaldehyde for 1 min at 37uC followed
by ice cold methanol for 1min at 220uC. Control and labeled cells
were permeabilized with 0.125%Triton X-100 or 0.001%
digitonin for 3 min and blocked with 1% BSA in PBS. Cells were
probed with NDRG1 primary antibody followed by fluorescent
labeled secondary antibodies for the two proteins and imaged.
Imaged stacks were processed by the Image J or Volocity software
before being made into Tiff/Jpeg files. For immunoprecipitation,
flag-tagged NDRG1 and Rab4a contructs were used. Constructs
were transfected in cell lines and 72 hour post transfection cells
were lysed by passing through a 21 gauge needle in Tris-buffered
saline containing protease (Roche) and phosphatase (Sigma)
inhibitors. Lysates were cleared by centrifugation and used for
immunoprecipitation with M2-conjugated agarose (Sigma). For
immunoprecipitations involving E-cadherin complex, lysates were
made in cell lysis buffer (20 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium
pyrophosphate, 1 mM sodium beta glycerophosphate) containing
protease and phosphatase inhibitors and then immunoprecipitated
using M2-agarose.
Tissue Array
A prostate cancer tissue array was performed according to our
published methods [18]. There were 68 cores of tumor from 32
patients that could be evaluated. Staining for the proteins were
carried out using Envision+kit (DakoCorp., Carpentaria, CA).
Tissue were also probed for CK8 for automated cellular analysis
and counterstained with Gill’s hematoxylin in a 1:4.5 dilution.
Stained slides were scanned using the ChromaVision ACIS II
system (ChromaVision Medical Systems, San Juan Capistrano,
CA) and values were normalized with CK8 staining. Spots with
a diagnosis of cancer or normal were averaged for each patient in
terms of average intensity of membrane staining for E-cadherin
and average intensity of overall staining for NDRG1. Briefly,
brown thresholds were adjusted to correlate with the immunopo-
sitive signal, whereas blue thresholds were adjusted for the nuclear
counterstain. Images were excluded from analysis if cores were
folded, absent, incomplete, or contained mixed tissue types. A
score for stained protein (NDRG1 or E-cadherin) was calculated
by dividing the brown area for the protein (in pixels) by the brown
area for keratin 8 (stained for epithelial cells) and then multiplying
by 100. Data was exported to Stata 8.0 for statistical analysis and
analyzed by Wilcoxon rank-sum test and regression analysis.
Recombinant proteins
Flag tagged NDRG1 was PCR amplified and cloned in pMT/
BiP/V5-His vector (Invitrogen). Stable Drosophila S2 transfec-
tants expressing the recombinant proteins were induced with
copper sulphate (500 mM) in a serum free media for 4 days.
Secreted protein was dialyzed in 10 mM Tris-HCl (pH 7.4) and
passed through Q-Sepharose column. Bound proteins were
subjected to a step-gradient of NaCl. Eluted protein was adjusted
to 150mM NaCl before being affinity purified with M2 agarose
(Sigma). Rab4a was amplified from a prostate cDNA library and
Figure 7. Live cell confocal microscopy confirms NDRG1 involvement with recycling E-cadherin. Live cell confocal images of stable NDRG1DsRed2-
HEK293 cells transfected transiently with E-cadherinEGFP construct and plated in calcium-supplemented media after being chelated with EDTA
shows NDRG1DsRed2 positive vesicles interact with recycling E-cadherinEGFP both near the perinuclear space and close to the membrane. The
image is a still from Movie S4.
doi:10.1371/journal.pone.0000844.g007
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in BL21 (DE3) cells. Recombinant proteins were confirmed by
Western Blotting.
Pull-Down assay
One microgram of purified Rab4aGTPase was loaded with either
100 mM GDP or 10 mM GTPcS in a HEPES binding buffer
(20 mM HEPES, 1 mM MgCl2, 1mM DTT and 100 mM
potassium acetate) for 30 min at 37u C and incubated with M2
agarose bound NDRG1Flag for 1h. Bound proteins were analysed
by Western blotting.
Transferrin Recycling assay
HEK293 cells were plated in a 12 well plate and transfected with
NDRG1shRNA and NDRG1 flag contructs with corresponding
control vectors. Forty eight hour post transfection cells were
subjected to a transferrin recycling assay [47]. Briefly, cells were
serum starved for 1h before the assay by replacing the serum
(10%FBS) containing MEM medium with MEM medium
supplemented with 2 mg/ml of BSA. After starvation the medium
was replaced with BSA supplemented media containing 10 ug/ml
of iron saturated biotinylated holotransferrin (Sigma) for 1h to load
the endosomal recycling compartment. Cells were chilled on ice
and washed twice with cold PBS and once with low pH wash
buffer (150 mM NaCl, 10 mM acetic acid pH 3.5) followed by
two washes with cold PBS. Recycling was initiated by addition of
complete medium supplemented with 1mg/ml of iron saturated
holotransferrin (Sigma). After different time points, cells were lysed
and processed for western blotting to quantitate the amount of
transferrin in the endosomal recycling compartment. To quanti-
tate recycled transferrin, a fraction of lysate and corresponding
media was used to precipitate biotinylated transferrin using
streptavidin agarose beads and processed for western blotting.
Biotinylated transferrin was detected by incubating blots with
streptavidin-HRP. Band intensities were quantitated by densitom-
etry using Versa Doc (BioRad). Recycled transferrin at each time
point was expressed as a percentage of total transferrin present in
the cells and media.
Endosome Recruitment Assay
Full length NDRG1 was PCR amplified using forward primer
engineered with a T7 promoter and Kozak sequence for in vitro
transcription and translation respectively. Amplified products were
in vitro transcribed using T7 RNA polymerase and in vitro translated
using reticulocyte lysate (Promega) in the presence of S
35
methionine (GE). Recycling and early endosomes were isolated
from HEK293 cells using step floatation sucrose gradient
ultracentrifugation. Fractions at the 35%–25% interphase contain-
ing recycling and early endosomes were subjected to immunoiso-
lation using Rab11 antibody (Zymed) bound to Miltenyi beads to
purify recycling endosomes. Twenty five microliters of in vitro
translated NDRG1 was incubated with Miltenyi beads bound
recycling endosomes, 1 mg of GTPcS bound Rab4 and HEK293
cytosol (2 mg/ml) with appropriate controls (refer to Figure 3D)
for 60min at 37uC. Endosomes were magnetically isolated, lysed
using Laemmli buffer and the proteins were separated on a 4–15%
SDS-PAGE gel and fluorographed.
Lipid Overlay analysis
Lipid arrays (Echelon Biosciences) were blocked and probed with
purified NDRG1flag (1 mg/ml) as per the manufacturer’s in-
struction. The array was developed using ECL after probing with
antibody against NDRG1.
Live Cell Confocal Microscopy
HEK293 cells were transfected with NDRG1DsRed2 constructs
using Lipofectamine 2000 reagent and stable clones were selected
using G418. For recycling experiments HEK293-DsRed2 cells
were plated on glass bottom petridishes (MatTek Corporation)
allowed to adhere for 12 h. Cells were serum starved for 1h before
being pulsed with Alexa flour-488 conjugated transferrin (45 mg/
ml) for 5 min to load the early endosomes and 60 min to load the
recyling endosomes. Recycling was initiated after washing cells in
PBS and adding excess of unconjugated iron-saturated holo
transferrin (1mg/ml). Live Cell confocal microscopy was carried
out using Utraview LCI (Perkin Elmer) equipped with Spinning
Nipkow disk with microlenses. Cells were viewed using a 1006
objective. Images were grabbed every second in the temporal
module, for 1–5 min using a LSI-cooled 12-bit CCD camera and
processed using the NIH ImageJ software (http://rsb.info.nih.
gov/ij/download.html) before being made into a movie. For
experiments involving E-cadherin trafficking, E-cadherinEGFP
constructs (a kind gift by Dr. James Nelson, Stanford University)
were transfected in NDRG1DsRed2-HEK293 cells. Twenty four
hours post transfection cells were imaged as above or chelated
using EDTA (2.5 mM) for 30 min and plated on glass bottom
petri dishes and then imaged as above.
SUPPORTING INFORMATION
Figure S1 NDRG1 interacts with recycling E-cadherin in DU-
145 cells. Immunofluorescence analysis of DU-145 cells chelated
with EDTA and replated on calcium-supplemented media
immunoprobed for NDRG1 and E-cadherin after different time
intervals. NDRG1 colocalizes with recycling E-cadherin. (Figure is
a representative of three independent experiments.)
Found at: doi:10.1371/journal.pone.0000844.s001 (7.29 MB TIF)
Figure S2 Purification of recombinant proteins. (A) Flag tagged
NDRG1 produced in insect cells was purified by anion exchange
chromatography, separated on SDS-PAGE gels and stained with
Coomassie blue stain. Fraction of the purified proteins eluted out
with 200mM and 300mM NaCl were analyzed by Western
blotting (lower panel). (B) Rab4aGST produced in BL21 (DE3)
cells was purified using glutathione agarose before being separated
by SDS-PAGE and stained with Coomassie. Each lane shows
successive elution of bound proteins using glutathione (15mM).
The protein was confirmed by western blotting (lower panel).
Found at: doi:10.1371/journal.pone.0000844.s002 (9.74 MB TIF)
Movie S1 Vesicular NDRG1 is located near the perinuclear
region. HEK293 cells were transfected with pCMVNDRG1-
DsRed2 vector. Stable cells were selected and imaged under
Utraview LCI (Perkin Elmer). The movie show Z sections
(0.15 mm) of cells from top to bottom. As seen, very few NDRG1
vesicles are located near the surface of cells and are mostly
concentrated near the perinuclear region.
Found at: doi:10.1371/journal.pone.0000844.s003 (6.89 MB AVI)
Movie S2 NDRG1 containing vesicles are motile and undergo
fission and homotypic fusion. HEK293 cells were transfected with
pCMVNDRG1-DsRed2 vector. Stable cells were selected and
imaged under Utraview LCI (Perkin Elmer). Images were grabbed
at the rate of 1image/sec and processed using ImageJ software
before being made into a movie. NDRG1 vesicles in the
perinuclear space also assume tubular morphology that rapidly
moves from the perinuclear space towards the plasma membrane,
a feature characteristic of recycling/sorting endosomal
compartment.
Found at: doi:10.1371/journal.pone.0000844.s004 (2.45 MB AVI)
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transferrin. NDRG1DsRed2-HEK293 cells were serum starved
for 1h and incubated with Alexa flour-488 conjugated transferrin
(45 mg/ml) for 60 min to load the recycling endosomes. Cells were
then imaged under Utraview LCI (Perkin Elmer) live cell confocal
microscope. Images were grabbed at the rate of 1image/sec and
processed using ImageJ software before being made into a movie.
Found at: doi:10.1371/journal.pone.0000844.s005 (0.35 MB
MOV)
Movie S4 NDRG1 interacts with recycling E-cadherin.
NDRG1DsRed2-HEK293 cells were transfected with pCMVE-
cadherinEGFP construct. Twenty four hours post transfection
calcium was chelated with EDTA (2.5mM) and cells were plated in
calcium-supplemented media before being imaged. Cells were
imaged using the Utraview LCI (Perkin Elmer) live cell confocal
microscope. Images were grabbed at the rate of 1image/sec and
processed using ImageJ software before being made into a movie.
NDRG1 vesicles near the perinuclear space and close to the
surface of the membrane localizes with E-cadherin as it is
trafficked back to the cell surface.
Found at: doi:10.1371/journal.pone.0000844.s006 (12.81 MB
AVI)
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